GlobeNewswire 11/6/2025 Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
GlobeNewswire 11/6/2025 Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors
GlobeNewswire 11/6/2025 Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
GlobeNewswire 11/5/2025 Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 11/5/2025 Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
GlobeNewswire 11/5/2025 MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from...
GlobeNewswire 11/5/2025 Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Out...
GlobeNewswire 11/5/2025 Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 11/4/2025 Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Da...
GlobeNewswire 11/4/2025 Kymera Therapeutics Announces Third Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire 11/3/2025 Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual M...
GlobeNewswire 11/3/2025 Recludix Pharma to Present at Two Investor Conferences in November
GlobeNewswire 11/3/2025 Kailera Therapeutics Appoints Frank Clyburn to Board of Directors
GlobeNewswire 11/3/2025 Draig Therapeutics Appoints Seasoned Neuroscience Leader Ivana Magovčević-Liebisch as President and ...
GlobeNewswire 10/31/2025 Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
GlobeNewswire 10/30/2025 Nurix Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 10/29/2025 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 20...
GlobeNewswire 10/28/2025 NodThera Announces Appointment of Chris Guiffre, J.D., M.B.A., as Chief Financial Officer
GlobeNewswire 10/28/2025 Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Dis...
GlobeNewswire 10/28/2025 Regeneron Reports Third Quarter 2025 Financial and Operating Results
GlobeNewswire 10/28/2025 Press release: Sanofi successfully prices USD 3 billion of bond issue
GlobeNewswire 10/28/2025 UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Imp...
GlobeNewswire 10/27/2025 NodThera Announces First Patients Dosed in RESOLVE-2 Clinical Trial Evaluating Oral NT-0796 in Combi...
GlobeNewswire 10/27/2025 Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock
TeleTrader 10/24/2025 Europe closes mixed amid earnings, US inflation